lasalocid and Poultry-Diseases

Topics: Acriflavine; Animal Feed; Animals; Coccidia; Coccidiosis; Coccidiostats; Drug Combinations; Drug Resistance, Microbial; Eimeria; Genetic Markers; Ionophores; Lasalocid; Monensin; Poultry; Poultry Diseases

Coccidiosis remains a significant threat to the welfare of game farm-reared pheasants in the United States. Although lasalocid has been demonstrated to be effective against pheasant specific coccidia, information regarding its safety in this species is lacking. The purpose of this study was to gather data on the safety of lasalocid when fed to Chinese ring-necked pheasants at one, two, and three times the recommended high dose of lasalocid used for prevention of coccidiosis in other poultry at three times the normal treatment period. Pheasant chicks (approximately 1 day-old; n = 160) were randomly blocked by sex into four treatment groups and given their respective diets continuously for 6 wk. No significant differences were observed in overall feed consumption, weight gain, feed conversion rates, clinical pathology measurements, or tissue gross and histopathologic evaluations between controls and treatment groups associated with lasalocid administration. Based on the results of this study it appears that lasalocid fed at the recommended rate of 125 ppm is safe in Chinese ring-necked pheasants.

Topics: Animal Nutritional Physiological Phenomena; Animals; Coccidiosis; Coccidiostats; Dose-Response Relationship, Drug; Feeding Behavior; Female; Galliformes; Lasalocid; Male; Poultry Diseases; Weight Gain

We evaluated the effects of dietary supplementation with different preparations of probiotics on the performance of broiler chickens experimentally infected with 2 × 10(4) sporulated oocysts of Eimeria tenella at 14 days of age. Three hundred, day-old, Cobb-500 chicks, as hatched, were separated into 10 equal groups with three replicates. Two of the groups, one challenged with E. tenella oocysts and the other not, were given a basal diet and served as controls without medication. The other challenged groups were given the anticoccidial lasalocid (60 mg/kg) or Enterococcus faecium (5 × 10(8) or 5 × 10(9)cfu/kg feed), Bifidobacterium animalis (5 × 10(8)cfu/kg feed), Lactobacillus reuteri (5 × 10(8)cfu/kg feed), Bacillus subtilis (5 × 10(8)cfu/kg feed), or a multi-species probiotic mix at 5 × 10(8) or 5 × 10(9)cfu/kg feed, respectively. The trial lasted 6 weeks. Individual body weight, feed intake per pen and feed conversion ratio values were recorded weekly, along with the extent of bloody diarrhea, excreta oocyst numbers and bird mortality. Caecal lesions were assessed and intestinal samples were taken for histopathological and bacteriological evaluation from ileum and caecum. Overall growth performance of chickens fed the multi-species probiotic mix at both levels was higher (P<0.05) compared to the infected control. Overall oocyst shedding was lowest (P<0.05) in the lasalocid supplemented group. Villous height was higher (P<0.05) in Bacillus supplemented groups compared to infected controls. The Lactobacillus supplemented group had the highest (P<0.05) numbers of both Lactobacillus and Bifidobacterium in ileum and caecum. In conclusion, dietary probiotics are promising for further investigation on improving intestinal health and growth performance of broiler chickens experimentally challenged with E. tenella.

Topics: Animals; Bacteria; Chickens; Coccidiosis; Dietary Supplements; Eimeria tenella; Female; Intestines; Lasalocid; Male; Poultry Diseases; Probiotics

Two battery efficacy studies were conducted with field isolates of Eimeria spp. from outbreaks of coccidiosis on pheasant-rearing farms in Georgia (GA) and Illinois (IL), United States. The coccidian isolates were mixed species containing E. phasiani, E duodenalis, and E colchici. Lasalocid (LAS) was tested prophylactically at 120 parts per million (ppm) in the feed. Anticoccidial activity was assessed, in comparisons between infected and uninfected control birds, by the effects on weight gain and oocyst passage. The GA isolate reduced weight gain of infected controls by 64% (P < 0.05) during the week after inoculation. LAS-treated birds also suffered some depressed gain, but average gains were significantly improved (P < 0.05) in comparison with that of the infected controls. Fecal oocyst counts of infected controls averaged 10-24 x 10(6)/day for days 5-11 postinoculation (PI), after which oocyst passage declined. Birds given LAS passed 10-20 x 10(6) oocysts on days 5-6 PI, after which counts dropped to much lower levels. Oocyst passage was significantly reduced (P < 0.05) by LAS treatment on all but days 5 and 6 PI. The IL isolate reduced weight gain by 36% in infected controls, relative to uninfected controls (P < 0.05). LAS-treated birds also suffered reduced gain, but the gain was significantly improved in comparison with the infected controls. Oocyst counts averaged 3-9 x 10(6)/day on days 6-14 PI, but were significantly reduced by LAS treatment on all but day 6 PI. Thus, LAS was effective in pheasants against the tested field isolates of Eimeria spp. and was well tolerated at 120 ppm in the feed. However, the level of control was not as high as previously observed. Possible explanations for this difference include an emergence of drug resistance from prior use of LAS and a differential efficacy of LAS against different species of Eimeria used in the studies.

Topics: Animals; Coccidiosis; Coccidiostats; Feces; Galliformes; Lasalocid; Parasite Egg Count; Poultry Diseases; Weight Gain

In this study, the effect of probiotic supplementation via drinking water or feed on the performance of broiler chickens experimentally infected with sporulated oocysts of Eimeria acervulina (5 × 10(4)), Eimeria maxima and Eimeria tenella (2 × 10(4) each one) at 14 days of age was evaluated. Two hundred and forty 1-day-old Ross 308 male chicks were separated into eight equal groups with three replicates. Two of the groups, one infected with mixed Eimeria oocysts and the other not, were given a basal diet and served as controls. The remaining groups were also challenged with mixed Eimeria species and received the basal diet and either water supplemented with probiotic (three groups) or probiotic via feed (two groups); the probiotic used consisted of Enterococcus faecium #589, Bifidobacterium animalis #503 and Lactobacillus salivarius #505 at a ratio of 6:3:1. Probiotic supplementation was applied either via drinking water in different inclusion rates (groups W1, W2 and W3) or via feed using uncoated (group FN) or coated strains (group FC). The last group was given the basal diet supplemented with the anticoccidial lasalocid at 75 mg/kg. Each experimental group was given the corresponding diet or drinking water from day 1 to day 42 of age. Throughout the experimental period of 42 days, body weight and feed intake were recorded weekly and feed conversion ratios were calculated. Seven days after infection, the infected control group presented the lowest weight gain values, while probiotics supplied via feed supported growth to a comparable level with that of the lasalocid group. Probiotic groups presented lesion score values and oocyst numbers that were lower than in control infected birds but higher than in the lasalocid group. In the duodenum, jejunum and ileum, the highest villous height values were presented by probiotic groups. In conclusion, a mixture of probiotic substances gave considerable improvement in both growth performance and intestinal health in comparison with infected control birds and fairly similar improvement to an approved anticoccidial during a mixed Eimeria infection.

Topics: Animal Feed; Animals; Bifidobacterium; Chickens; Coccidiosis; Coccidiostats; Dietary Supplements; Eimeria; Enterococcus faecium; Feces; Intestines; Lactobacillus; Lasalocid; Oocysts; Poultry Diseases; Probiotics; Water; Weight Gain

Three trials were conducted to evaluate the effects of lasalocid, an anticoccidial feed additive (90.7 kg/ton); bacitracin, a growth-promoter (50 g/ton); and yeast culture residue (YCR) (1 kg/ton) on the performance of broiler chicks reared to 42 d of age on recycled litter. Recycled litter consisted of pine wood shavings containing droppings from chicks infected with 3 select strains of coccidia (Eimeria tenella, Eimeria maxima, and Eimeria acervulina). Response variables (BW, intestinal tract and litter coliform counts, cecal and liver relative weights, and litter moisture content) were recorded biweekly. Mean BW of chicks fed the diet supplemented with YCR was higher than that of the controls (P < 0.05) and comparable to that of the lasalocid-treated birds in all 3 trials. Mean BW of chicks in all treatment groups decreased uniformly as the litter aged and moisture content increased. The mean intestinal coliform population from YCR-treated chicks was lower (P < 0.05) than those of the control and lasalocid populations. The coliform count was consistently lower than that in chicks on a bacitracin-supplemented diet. Coliform counts from the control and lasalocid-treated birds did not differ. The litter coliform counts increased with increased use of the litter. Cecal and liver relative weights calculated from the chicks in trial 3 showed that only the liver was significantly affected by treatments. YCR appeared to be a viable alternative to bacitracin and lasalocid medication in enhancing growth of broiler chicks reared on recycled litter.

Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Bacitracin; Cecum; Chickens; Coccidiosis; Coccidiostats; Colony Count, Microbial; Eimeria; Feces; Floors and Floorcoverings; Housing, Animal; Lasalocid; Male; Organ Size; Poultry Diseases; Probiotics; Weight Gain; Yeasts

Eimeria parasites were isolated from Nanhai Guangdong province (southern China) and studied in chickens in wire cages to evaluate their drug resistance against commonly used ionophores: monensin (100 mg/kg of feed), lasolacid (90 mg/kg), salinomycin (60 mg/kg), maduramicin (5 mg/kg) and semduramicin (25 mg/kg). Chinese Yellow Broiler Chickens were infected with 40,000 crude sporulated Eimeria oocysts at 15 days of age and prophylactic medication commenced a day prior to infection. Drug resistance was assessed for each ionophore drug by calculating the anticoccidial index (ACI) and percentage optimum anticoccidial activity (POAA) based on relative weight gain, rate of oocyst production and lesion values. Results revealed that Nanhai Eimeria oocysts comprising of E. tenella, E. maxima and E. acervulina, were resistant to monensin, sensitive to both salinomycin and lasolacid and partially sensitive to maduramicin and semduramicin. By selection for early development of oocysts during passage through chickens, the prepatent time of E. tenella, E. maxima and E. acervulina were reduced by 49, 36 and 22 h, respectively. The precocious lines are less pathogenic than the parent strains from which they were selected and conferred a satisfactory protection for chickens against coccidiosis. These ionophore-tolerant precocious lines could have wider applications in the development of anticoccidial vaccines for sustainable control of coccidiosis.

Topics: Animals; Chickens; Coccidiosis; Coccidiostats; Drug Resistance; Eimeria; Eimeria tenella; Ionophores; Lactones; Lasalocid; Monensin; Nigericin; Oocysts; Parasitic Sensitivity Tests; Poultry Diseases; Pyrans; Random Allocation; Treatment Outcome

A study was carried out to examine the effect of dietary supplementation of oregano essential oil on performance of broiler chickens experimentally infected with Eimeria tenella at 14 days of age. A total of 120 day-old Cobb-500 chicks separated into 4 equal groups with three replicates each, were used in this study. Two groups, one infected with 5 x 10(4) sporulated oocysts of E. tenella and the other not, were given a basal diet and served as controls. The other two groups also infected with E. tenella were administered diets supplemented with oregano essential oil at a level of 300 mg/kg, or with the anticoccidial lasalocid at 75 mg/kg. Following this infection, survival rate, bloody diarrhoea and oocysts excretion as well as lesion score were determined. Throughout the experimental period of 42 days, body weight gain and feed intake were recorded weekly, and feed conversion ratios were calculated. Two weeks after the infection with E. tenella supplementation with dietary oregano oil resulted in body weight gains and feed conversion ratios not differing from the non-infected group, but higher than those of the infected control group and lower than those of the lasalocid group. These parameters correspond with the extent of bloody diarrhoea, survival rate, lesion score and oocyst numbers and indicated that oregano essential oil exerted an anticoccidial effect against E. tenella, which was, however, lower than that exhibited by lasalocid.

Topics: Animals; Chickens; Coccidiosis; Coccidiostats; Dietary Supplements; Eating; Eimeria tenella; Female; Lasalocid; Male; Oils, Volatile; Oocysts; Origanum; Poultry Diseases; Random Allocation; Survival Analysis; Weight Gain

Seven anticoccidial drugs commonly used in poultry (diclazuri), monensin, salinomycin, halofuginone, nicarbazin, robenidine, amprolium, and lasalocid) were tested for residual activity after withdrawal. In each test, the products were given at the recommended level to cages of 10 broiler chickens. Oral inoculation with coccidia was given after withdrawal of medication. Birds pretreated with 1 ppm of diclazuril and inoculated with Eimeria tenella after drug withdrawal had normal weight gain and very low lesion scores. Residual activity depleted gradually over several days, as shown by higher lesion scores when medication was withdrawn for up to 3 days before inoculation. Similar results were observed when young birds were inoculated with a mixture of E. tenella, E. maxima and E. acervulina, and also when birds were given diclazuril to market weight (6 weeks of age) and inoculated with a mixture of six species of Eiméria (The above species plus E. brunetti, E. mitis, and E. necatrix) after withdrawal of medication for 2 days. In contrast, there was no evidence of residual anticoccidial activity with nicarbazin, halofuginone, lasalocid, amprolium, salinomycin or monensin. Overall, the residual activity was unique to diclazuril.

Topics: Amprolium; Animal Feed; Animals; Chickens; Coccidiosis; Coccidiostats; Eimeria tenella; Feces; Female; Lasalocid; Male; Monensin; Nicarbazin; Nitriles; Piperidines; Poultry Diseases; Pyrans; Quinazolines; Quinazolinones; Random Allocation; Triazines

Three battery tests were conducted to reveal whether or not there is an interaction between the new dihydroquinoline antioxidant, duokvin and lasalocid or the new anticoccidial, semduramicin, similar to that observed with some other ionophorous anticoccidials. In terms of body weight gain, no significant difference due to toxic interaction between duokvin and any dose of lasalocid or semduramicin was detected in chickens experimentally infected with oocysts of Eimeria tenella and E. mitis. Anticoccidial efficacy at reduced doses of both lasalocid and semduramicin in combination with duokvin showed numerical improvement; however, this again proved to be insignificant. The lack of incompatibility of this antioxidant with lasalocid or semduramicin allows their simultaneous administration on the one hand, but it fails to enable a substantial reduction of the chemoprophylactic concentration of anticoccidials in the broiler ration on the other.

Topics: Animals; Chickens; Coccidiosis; Coccidiostats; Drug Interactions; Eimeria; Ionophores; Lasalocid; Nigericin; Poultry Diseases; Quinolines

Lasalocid sodium was accidentally introduced into the feed of several broiler breeder chicken farms at levels between 115 and 150 ppm. On one farm, leg weakness and ataxia were observed in a few cockerels. A reduction in egg production and a sharp decrease in fertility and hatchability were observed in all the flocks receiving the contaminated feed. Many piping chicks were unable to hatch and there was an increase in the number of weak ataxic chicks at the hatchery. Histological examination of the muscle tissues of the affected cockerels, the piping chicks unable to hatch and the one-day-old chicks with leg weakness and ataxia revealed severe muscle damage. Increasing levels of lasalocid were detected in the yolk of eggs collected from the affected flocks.

Topics: Animal Feed; Animals; Ataxia; Chickens; Female; Fertility; Food Contamination; Lasalocid; Male; Muscles; Oviposition; Poisoning; Poultry Diseases

Forty-six broiler houses were examined for the presence of oocysts of Eimeria in the litter before and after withdrawal of lasalocid or salinomycin from the feed. A decrease in number of small oocysts (Eimeria acervulina or Eimeria mitis) was observed following withdrawal of medication. Numbers of medium-sized oocysts (probably Eimeria tenella) remained the same, but an increase in large oocysts (Eimeria maxima) was recorded. No lesions attributable to Eimeria tenella were found in the ceca of birds after withdrawal of the drug. More small- and medium-sized oocysts were found at sites with new litter than at sites where the litter had been employed for previous flocks. No difference in the number of oocysts was found, whether birds were reared on oak shavings or a mixture of pine shavings and rice hulls. The number of oocysts was positively correlated with the moisture content of the litter, but there was no correlation between oocysts present and the final BW or feed conversion of the birds. Moisture levels were highest (after withdrawal of drug) for new litter or oak shavings. There was no correlation between moisture content of the litter and BW or feed conversion.

Topics: Animals; Cecum; Chickens; Coccidiosis; Coccidiostats; Eimeria; Feces; Lasalocid; Poultry Diseases; Pyrans

Two battery tests were carried out to reveal whether or not there is an interaction between T-2 fusariotoxin and lasalocid, similar to that known with some ionophorous anticoccidials. In the first experiment, an excessive dose level of toxin (6 ppm) significantly reduced the anticoccidial efficacy of lasalocid at 75 ppm and almost completely eliminated that at 37.5 ppm in cockerels which had been infected with oocysts of Eimeria tenella and E. mitis. In the second experiment, the same dose of lasalocid was tested in combination with 0.5-1.25 ppm levels of toxin, i.e. levels occurring in the field, and all but the lowest level (0.5 ppm) significantly reduced the anticoccidial efficacy of lasalocid. Thus, in cases of outbreaks of coccidiosis, there is need to keep in mind such interaction between anticoccidials and mycotoxins.

Topics: Animals; Chickens; Coccidiosis; Lasalocid; Male; Poultry Diseases; T-2 Toxin

Broiler chickens in battery pens were either fed a diet containing 100 ppm lasalocid or no drug for 24 h prior to inoculation with sporulated oocysts of Eimeria tenella or Eimeria acervulina. Different groups of birds remained on medicated feed for 24, 48, 72, 96, 120 or 144 h after inoculation. Conversely, other groups started on an unmedicated diet, were given medicated feed at different times after oocyst inoculation. Starting lasalocid medication 24 h (E. tenella) or 48 h (E. acervulina) after inoculation reduced the lesions and improved the weight gain. There was no significant difference in performance of birds after withdrawal of the drug at 48 h (E. tenella) or 72 h (E. acervulina) and thereafter. Starting lasalocid medication at 96 or 120 h did not suppress but rather reduced oocyst production.

Topics: Animals; Chickens; Coccidiosis; Eimeria; Lasalocid; Poultry Diseases; Weight Gain

Lasalocid and monensin are widely used to control coccidiosis in broilers, but not in turkey poults. Four feeding trials were conducted to determine the performance of turkey poults when these compounds were used singly or in combination with 100 ppm of furazolidone. Bodyweights and feed consumption were significantly depressed for five weeks after hatching by 150 ppm of lasalocid. Combining furazolidone with lasalocid ameliorated the toxic effect of lasalocid. Bodyweights were significantly depressed by 150 ppm of monensin in the fifth week after hatching, but there was no significant depression in feed consumption. Furazolidone exacerbated any toxic effects of monensin. Data indicate that monensin may be used safely at dosages greater than the recommended level of 60 to 99 ppm, but should not be used in combination with furazolidone.

Topics: Animal Feed; Animals; Bacterial Infections; Body Weight; Coccidiosis; Drinking; Drug Interactions; Eating; Furazolidone; Lasalocid; Male; Monensin; Poultry Diseases; Random Allocation; Turkeys

Isolates of Eimeria species obtained from broiler or from breeder farms were compared for their sensitivity to two ionophorous anticoccidial drugs, monensin and lasalocid. All of 25 isolates from broiler farms were resistant to 100 ppm monensin or 90 ppm lasalocid, while 14 of 16 isolates were resistant to monensin and seven of 16 to lasalocid from breeder farms (replacement layer and broiler breeder).

Topics: Animals; Cecum; Chickens; Coccidiosis; Eimeria; Feces; Lasalocid; Monensin; Poultry Diseases

The activities of five anticoccidials were compared against Eimeria species in/of chickens, in controlled in vivo and in vitro laboratory studies. Two more recent and potent market entries (maduramicin and halofuginone) were compared with three older polyether antibiotic anticoccidials (monensin, lasalocid and salinomycin). Halofuginone, lasalocid, maduramicin, monensin and salinomycin were evaluated at 3, 125, 5, 120 and 66 ppm, respectively, of active drug in the diets. At these levels, all five drugs demonstrated significant activity against Eimeria tenella, E. maxima, E. necatrix, E. brunetti and E. acervulina (in vivo). Monensin was least effective against E. tenella, and one of the lesser efficacious drugs against E. necatrix, maduramicin, was least effective against E. maxima. In studies of single Eimeria species infections, comparable weight gains were noted for the drugs. In the mixed Eimeria species infections, however, birds treated with maduramicin had significantly higher weight gains than did birds medicated with monensin. Unlike in vivo potencies, titration in vitro indicated that monensin was most potent (active at 10(-6) mcg ml-1), and maduramicin and lasalocid least potent (inactive at less than or equal to 10(-3) mcg ml-1).

Topics: Animals; Anti-Bacterial Agents; Body Weight; Chickens; Coccidiosis; Coccidiostats; Eimeria; Female; Ionophores; Lactones; Lasalocid; Male; Monensin; Piperidines; Poultry Diseases; Pyrans; Quinazolines; Quinazolinones

An investigation involving 640 turkeys demonstrated that the inclusion of lasalocid continuously from day-old to 16 weeks of age, at levels up to 375 ppm in the feed, produced no adverse effects; furthermore, the inclusion of 125 ppm lasalocid in the feed was compatible with the administration of 250 ppm tiamulin in the drinking water continuously for five days to turkeys over the same age range.

Topics: Animal Feed; Animals; Anti-Bacterial Agents; Body Weight; Coccidiosis; Diterpenes; Drinking; Eating; Female; Lasalocid; Male; Organ Size; Poultry Diseases; Turkeys

Topics: Animals; Chickens; Coccidiosis; Coccidiostats; Eimeria; Ionophores; Lasalocid; Monensin; Poultry Diseases; Pyrans

Topics: Animal Feed; Animals; Chickens; Coccidiosis; Drug Stability; Lasalocid; Poultry Diseases

Topics: Animals; Chickens; Coccidiosis; Eimeria; Female; Immunization; Lasalocid; Male; Poultry Diseases

Chemoprophylaxis of Cryptosporidium baileyi infections was attempted by feeding 4 groups of chicks diets containing 3 mg of halofuginone/kg of feed, 60 mg of salinomycin/kg, 75 mg of lasalocid/kg, or 110 mg of monensin/kg. Rations were fed 5 days before oral or intratracheal inoculation with oocysts and were continued for 20 days. None of the drugs prevented C baileyi infections. Clinical signs of respiratory tract disease and gross lesions of airsacculitis were observed in intratracheally inoculated birds in all treatment groups and nonmedicated controls. Orally inoculated birds did not develop clinical signs of infection. Pathogenic bacteria were not isolated from the respiratory tract systems of any chicks. Halofuginone delayed the establishment of infections of the bursa of Fabricius and cloaca, but not of the trachea.

Topics: Animals; Chickens; Coccidiostats; Cryptosporidiosis; Lasalocid; Monensin; Piperidines; Poultry Diseases; Pyrans; Quinazolines; Quinazolinones

Two growth experiments were conducted to evaluate in broiler chicks the compatibility between lasalocid medication in the feed (at 90 or 125 ppm) and a long-term administration of chloramphenicol either via the feed (500 ppm) or via the drinking water (500 mg/liter). The simultaneous administration of lasalocid and chloramphenicol generally caused severe growth depression, decreased feed intake and impaired feed conversion. Several chicks showed evident symptoms of intoxication, such as ataxia, leg weakness and paralysis. The development and frequency of these symptoms were dependent on the dosage of lasalocid and on the duration of the simultaneous administration. Biochemical examinations (Experiment 2) revealed in the affected chicks significant changes in several parameters, in particular a markedly increased activity of creatine kinase and GOT in the plasma. It confirmed that the observed leg weakness and paralysis were caused by myodegeneration.

Topics: Animal Feed; Animals; Aspartate Aminotransferases; Ataxia; Body Weight; Chickens; Chloramphenicol; Creatine Kinase; Drug Incompatibility; Drug Therapy, Combination; Eating; Female; Lasalocid; Male; Paralysis; Poultry Diseases

Prophylactic levels of three ionophorous antibiotics, monensin, salinomycin, and lasalocid, were administered to groups of chickens and turkeys. All three ionophores markedly inhibited invasion of cecal tissues by sporozoites of ionophore-sensitive (IS) Eimeria tenella. Monensin and salinomycin also reduced invasion in turkeys by sporozoites of E. adenoeides, but lasalocid only minimally inhibited invasion. Invasion of ceca of monensin-medicated chickens was significantly greater by sporozoites of ionophore-resistant (IR) E. tenella than of the IS isolate. Concomitant experiments showed significant differences in [14C]monensin accumulation among IS and IR isolates of E. tenella. The decreased uptake of monensin by the IR isolates appeared to be accompanied by a decrease in responsiveness to the activity of monensin as well as to two other ionophores, salinomycin and narasin in cell culture. The amount of monensin, salinomycin or narasin required to inhibit development of E. tenella by 50% was 20 to 40 times higher for the IR isolates than for the IS ones. Collectively, the data suggest that differences in ionophore accumulation by IS and IR isolates of E. tenella might reflect differences in membrane chemistry and that these differences are responsible for the expressions of resistance that were observed in these studies. This expression of resistance appears to be common to all ionophores tested.

Topics: Animals; Chickens; Coccidiosis; Coccidiostats; Drug Resistance; Ionophores; Lasalocid; Monensin; Poultry Diseases; Pyrans; Turkeys

Four isolates of Eimeria tenella obtained from the field were partially resistant to monensin. This resistance was not lost after 10 passages in unmedicated chickens, indicating that it was stable. One of the four isolates was examined and found to be resistant also to narasin, salinomycin and lasalocid.

Topics: Animals; Chickens; Coccidiosis; Coccidiostats; Drug Resistance, Microbial; Eimeria; Ionophores; Lasalocid; Monensin; Poultry Diseases; Pyrans

The following conclusions are made from an introductory investigation on the use of the coccidiostat lasalocid on 11 production farms of an integrated broiler production organisation. In terms of the incidence of sub-clinical coccidiosis, no significant difference was found between the previous use of monensin and the use of lasalocid during the investigation. However, the incidence of coccidiosis decreased with the introduction of lasalocid. Despite the fact that on some farms sub-clinical coccidiosis was diagnosed, the production performance clearly improved with lasalocid. EBI figures significantly increased from 163.6 to 172.5. During the investigation, in which approximately 220,000 broilers were involved, litter quality did not differ from that of previous crops in which monensin had been used. Feathering of the broilers in the trial crops in which lasalocid was used was similar to that of previous crops.

Topics: Animals; Body Weight; Chickens; Coccidiosis; Eimeria; Feathers; Furans; Ionophores; Lasalocid; Poultry Diseases

Topics: Animal Feed; Animals; Cattle; Lasalocid; Poultry; Poultry Diseases; Spinal Cord Diseases

The effects of age vs. diet, potassium level, tetramethylthiuram disulfide (thiuram), and ionophores in the diet on the development of tibial dyschondroplasia in broilers was investigated. Changing broiler chicks from a diet that induced tibial dyschondroplasia to one that reduced the disease or vice versa caused a change in the incidence in the direction of the last-fed diet; however, in most cases the chicks did not develop as low or high an incidence of tibial dyschondroplasia as the birds fed the reducing or inducing diet, respectively, for the entire experimental period. Potassium supplementation of a corn-soybean meal diet that contained .88% potassium had no effect on the incidence of tibial dyschondroplasia. However, supplementation of a low potassium (.3%) corn-corn gluten meal-animal protein diet with potassium increased the incidence of tibial dyschondroplasia. The addition of thiuram to the diet caused an increase in tibial dyschondroplasia. When thiuram was added to the tibial dyschondroplasia-inducing diet, it also caused a decrease in bone ash and in the total and ultrafilterable plasma calcium. A significant negative correlation was obtained between incidence and score of tibial dyschondroplasia and bone ash of the ends and middles of the tibia when thiuram was fed. No consistent effects of the ionophores monensin and lasalocid on the development of tibial dyschondroplasia in broilers was noted in three experiments, although significant effects of the ionophores on the incidence or score of the disease was observed in two experiments.

Topics: Animals; Chickens; Diet; Lasalocid; Monensin; Osteochondrodysplasias; Potassium; Poultry Diseases; Thiram; Tibia

Topics: Animals; Chickens; Culture Media; Lasalocid; Leucomycins; Male; Mycoplasma; Mycoplasma Infections; Poultry Diseases; Species Specificity; Tylosin

The effect of restricted medication with lasalocid sodium on the development of acquired immunity against Eimeria tenella was evaluated. The medication was allowed for all or part of 6-day test period (one day before until 4 days after infection). The parameters used for such evaluations were lesion score, caecal, bursal and splenic weights. The optimum treatment time for the drug was clearly indicated by lesion score which was very low when the medication was initiated 1 day before until 1 day after inoculation, but only partly effective if given on Day 2 post-inoculation. The challenge with higher doses on 14th day of immunizing infection revealed a reverse picture where the higher lesions were recorded by the groups where medication was started earlier than the delayed treatment groups. This indicates partial interference with the development of immunity in the earlier treatment groups. Birds treated on Day 4 p.i. were not significantly different (P less than 0.05) from the infected unmedicated control group, suggesting no interference in acquired immunity. A correlation was noticed between day of treatment, the lesion score and weight gain of the caecum as well as the spleen. After both immunizing and challenge infections, the bursa did not show any significant variation in weight, whereas the weight of the spleen did vary. The infected unmedicated group and the delayed-treatment groups had a comparatively higher splenic weight than the uninfected unmedicated group of birds.(ABSTRACT TRUNCATED AT 250 WORDS)

Topics: Animals; Body Weight; Bursa of Fabricius; Cecum; Chickens; Coccidiosis; Eimeria; Immunity; Lasalocid; Male; Organ Size; Poultry Diseases; Spleen

Utilization of amino acids, sulfur-containing amino acid (SAA) in particular, is little affected by antibiotic and anticoccidial compounds. Coccidiosis (i.e., Eimeria acervulina infection) likewise seems to have little effect on SAA utilization. Copper sulfate, a commonly used antibacterial-antifungal compound (used at levels of 100-250 mg/kg diet), interacts with SAA. Hence, at upper levels of copper ingestion (i.e., 250 mg/kg and higher), copper binds SH compounds such as cysteine and reduced glutathione. Dietary SAA requirements are increased in both chicks and rats by dietary copper levels of 250 or 500 mg/kg. Hepatic copper deposition is enhanced by copper feeding and also by E. acervulina infection. These two effects, moreover, appear to be additive. The organic arsenic compound, roxarsone, interacts with SAA also, but in a different way. Thus, whereas added dietary cysteine partially ameliorates copper toxicity due to the binding of copper by cysteine-SH with subsequent excretion, roxarsone toxicity (i.e., 500 mg/kg diet) is exacerbated by supplemental cysteine.

Topics: Amino Acids; Amino Acids, Sulfur; Animals; Anti-Bacterial Agents; Arsenicals; Chickens; Coccidiosis; Coccidiostats; Copper; Lasalocid; Monensin; Poultry Diseases

Topics: Animals; Anti-Bacterial Agents; Chickens; Coccidiosis; Coccidiostats; Drug Combinations; Eimeria; Ionophores; Lasalocid; Male; Monensin; Poultry Diseases; Pyrans

Lasalocid (.0125%) alone and combined with roxarsone (.005%) was evaluated for its effect on lesion reduction and oocyst suppression in thirty-five controlled replicated battery experiments, using in excess of 6200 broiler chickens. The chickens were inoculated with field isolates containing predominantly Eimeria tenella species. Lasalocid (.0125%) used alone exhibited a high degree of anticoccidial activity. Lasalocid (.0125%) fed in combination with roxarsone (.005%) showed, in addition to high anticoccidial activity, a further reduction in gross lesion (P less than .01) and oocyst production (P less than .05) over lassalocid used alone.

Topics: Animals; Arsenicals; Chickens; Coccidiosis; Drug Therapy, Combination; Eimeria; Lasalocid; Poultry Diseases; Roxarsone

Lasalocid at the concentration of .0075% (68 g/ton) with and without roxarsone 45.4 g/ton was fed in combination with the growth promotants bacitracin methylene disalicylate 200 g/ton, bambermycins 2 g/ton, lincomycin 4 g/ton, nosiheptide 2.5 g/ton, zinc bacitracin 200 g/ton g/ton, and virginiamycin 20 g/ton exhibited a high degree of anticoccidial activity against mixed Eimeria infection in chickens in 9 day challenged battery trials. In these short term challenge trials chicks fed lasalocid, and the lasalocid growth promotant combinations, performed significantly better (P < .05) for growth and anticoccidial efficacy than those fed the growth promotants alone, and the infected, unmedicated controls. In almost all instances, the lasalocid-roxarsone-antibiotic combinations allowed for numerical increases in gains, improvement in feed conversion, and numerical decreases in lesions (in some cases, statistically significant (P < .05) over chicks fed lasalocid alone and/or the lasalocid antibiotic combination. The growth promotants did not interfere with the anticoccidial activity of lasalocid. The growth promotants fed alone exhibited no anticoccidial activity. However, when roxarsone was combined with the antibiotics, the combination resulted in numerically improved performance, reduced mortality, and in most instances, statistically significant decreases in lesions (P .05) over the infected, unmedicated control.

Topics: Animals; Arsenicals; Chickens; Coccidiosis; Drug Therapy, Combination; Lasalocid; Poultry Diseases; Roxarsone

Lasalocid was tested at graded feed concentrations in controlled battery experiments against single and mixed Eimeria species infections in 2-week-old turykey poults. Eimeria meleagrimitis, E. gallopavonis, E. adenoeides, and E. dispersa infected poults medicated with lasalocid at concentrations of 0.15, .0125, .01, .0075, and .005% were heavier, converted feed more efficiently, showed lower lesion scores (ADI), shed fewer oocysts, and showed reduced or no mortality as compared to the infected, unmedicated controls. Lasalocid activity was similar against the few field isolates tested. Lasalocid responses were dose related, the higher the concentration, the greater the effect. The optimum dose level in these battery studies was approximately .0125%. Lasalocid fed at two times the optimum dose level to poults for a four week period did not have any adverse effect on growth or feed conversion performance.

Topics: Animals; Body Weight; Coccidiosis; Lasalocid; Monensin; Poultry Diseases; Turkeys

Topics: Animals; Chickens; Coccidiosis; Coccidiostats; Furans; Ionophores; Lasalocid; Male; Monensin; Poultry Diseases; Pyrans

Topics: Animals; Anti-Bacterial Agents; Chickens; Coccidiosis; Coccidiostats; Furans; Lasalocid; Monensin; Poultry Diseases; Pyrans

The anticoccidial activities of monensin and lasalocid have been studied separately and in combination with tiamulin, a new pleuromutilin derivative. Combinations of constant tiamulin concentration (.0125%) in drinking water with various levels of polyether anticoccidials (6.3 to 125 ppm) in feed and conversely of constant levels of anticoccidials with various concentrations of tiamulin were used. The prophylactic efficacy of these combined treatments in battery raised broiler chickens infected with Eimeria tenella was evaluated. Assessment of the parameters mortality, weight gain, dropping scores, lesion scores, and oocyst output showed that simultaneous application of tiamulin significantly improved the anticoccidial activity of the polyethers. As tiamulin alone is without anticoccidial activity, this phenomenon was considered to result from an interaction between tiamulin and the polyethers leading to a slower metabolic degradation of the latter. Thus tissue levels adequate for maximum anticoccidial activity would be attained with lower polyether dose levels. Experiments using isolated perfused rat liver showed that elimination of monensin was reduced by 60% in the presence of tiamulin.

Topics: Animals; Anti-Bacterial Agents; Chickens; Coccidiosis; Coccidiostats; Diterpenes; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Lasalocid; Liver; Monensin; Poultry Diseases; Rats

Lonomycin (TM-481, SQ 12,525) at various concentrations in the feed was tested in controlled battery experiments against laboratory strains of single and mixed Eimeria species infections. The experimental results indicated that lonomycin at doses of .003125, .00625, or .0125% demonstrated a high degree of anticoccidial activity by preventing or reducing mortality, reducing fecal dropping scores, and allowing for normal or near-normal weight gains against single and mixed infections of 5 major pathogenic species, E. acervulina, E. brunetti, E. maxima, E. necatrix, and E. tenella. Lonomycin, at these same dosages, was highly effective against a recent field isolate obtained from a flock previously fed monensin. These studies involving 7 trials totaling 1,680 broiler chicks, have demonstrated that lonomycin at levels of .003125 to .0125% (dependent on species of Eimeria) in the feed is an effective aid in the control of avian coccidiosis in broiler chickens.

Topics: Administration, Oral; Animal Feed; Animals; Anti-Bacterial Agents; Body Weight; Chickens; Coccidiosis; Coccidiostats; Ethers; Female; Lasalocid; Male; Monensin; Nigericin; Poultry Diseases

The anticoccidial activity of lasalocid, monensin, and roxarsone, alone and in combination, was evaluated against eleven Eimeria tenella recent field isolates. Lasalocid was used at 0.0075. 0.01, and 0.0125% activity drug in feed; monensin at 0.0099 and 0.0121%; and roxarsone at 0.005%. Further studies with lasalocid 0.0075%, monensin 0.0099% and roxarsone 0.005 and 0.0025% combinations were carried out against three E. tenella field isolates selected from the aforementioned strains. Lasalocid and monensin each exhibited a high degree of anticoccidial activity at all concentrations tested. Lasalocid and monensin fed in combination with roxarsone showed, in addition to high anticoccidial activity a further reduction in gross lesions and oocysts production, more pronounced at 0.005% level of roxarsone than at 0.0025%, compared to either medication alone or the roxarsone combinations. These positive effects were noted with all strains tested. The practical aspects of these findings are discussed.

Topics: Administration, Oral; Animal Feed; Animals; Anti-Bacterial Agents; Arsenicals; Chickens; Coccidiosis; Drug Combinations; Feces; Female; Furans; Lasalocid; Male; Monensin; Poultry Diseases; Roxarsone

The anticoccidial efficacy, host tolerance, and projected resistance development of the three polyether antibiotics, monensin, narasin, and lasalocid were compared. The efficacy of narasin against different coccidial strains was found to parallel that of monensin in as much as strains which were refractory to monensin were also refractory to narasin. In contrast, lasalocid easily controlled some strains which were not well controlled by either narasin or monensin and failed to control one strain readily controlled by these two antibiotics. In growing chicks, lasalocid at the projected use level of 75 p.p.m. and narasin at an efficacious level of 100 p.p.m. were both better tolerated than monensin at the recommended use level of 121 p.p.m. The frequency of mutants resistant to each of these polyether compounds was found to be less than 8.6 X 10(-9) per drug sensitive oocyst for one strain of Eimeria tenella. This corresponds to less than 0.036 and 0.148 as frequent as mutants of this strain resistant to glycarbylamide or to amquinate, respectively.

Topics: Animals; Anti-Bacterial Agents; Chickens; Coccidiosis; Drug Resistance; Feces; Female; Furans; Lasalocid; Male; Monensin; Mutation; Poultry Diseases; Pyrans

The activities of monensin, lasalocid and halofuginone against Eimeria tenella, E. brunetti and E. necatrix have been studied under laboratory conditions. Complete control of experimental infections in the chick, separable from toxicity, was not obtained with monensin, but was achieved with the other two compounds at levels of 150 and 6 ppm in the food respectively. All three compounds appear to inhibit coccidial development very early in the life-cycle, and to have a fairly rapid lethal effect, monensin and lasalocid more so than the febrifugine derivative. In vivo observations have been supplemented with in vitro studies. Some discussion of the difficulties of relating laboratory experiments to field performance is given.

Topics: Administration, Oral; Animal Feed; Animals; Chickens; Coccidiosis; Coccidiostats; Eimeria; Feces; Lasalocid; Monensin; Piperidines; Poultry Diseases; Quinazolines; Quinazolinones

Eimeria tenella was passaged in the presence of suboptimal and optimal concentrations of lasalocid (X-537A, sodium salt) in feed. Lasalocid was equally active at concentrations of 0.006 and 0.0075% against the 10th and 15th passage of E. tenella lasalocid exposed strains. Resistance to lasalocid could not be induced. Lasalocid administered in the feed at 0.0075% was tested in controlled battery experiments against E. tenella strains resistant to known anticoccidials in chicks. These studies demonstrated that lasalocis, at the optimal feed concentration of 0.0075% was highly effective against coccidiosis induced by strains of E. tenella resistant to sulfaquinoxaline, nicarbazine, zoalene, emprolium, clopidol and 4-hydroxyquinoline. Lasalocid medicated chicks were heavier, converted feed more efficiently, showed less pathologic lesions, and had lower mortality (P less than or equal to .05) than the infected unmedicated controls as well as sulfaquinoxaline, nicarbazine, zoalene, amprolium-ethopabate, clopidol, buquinolate, decoquinate and nequinate medicated groups. Cross-resistance to lasalocid was not demonstrated.

Topics: Amprolium; Animals; Anti-Bacterial Agents; Clopidol; Coccidiosis; Coccidiostats; Dinitolmide; Drug Resistance; Eimeria; Feces; Female; Hydroxyquinolines; Lasalocid; Male; Nicarbazin; Poultry Diseases; Sulfaquinoxaline